GTHX

G1 Therapeutics, Inc. Common Stock

Delisted

GTHX was delisted on the 17th of September, 2024.

72 hedge funds and large institutions have $15.8M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
23
Reduced
21
Closed
17
Calls
$585K
Puts
$82K
Net Calls
+$503K
Net Calls Change
-$279K
Name Holding Trade Value Shares
Change
Shares
Change %
GCM
76
Graham Capital Management
Connecticut
-$139K -55,805 Closed
UBS AM
77
UBS AM
Illinois
-$106K -39,600 Closed
Allspring Global Investments
78
Allspring Global Investments
North Carolina
-$78.3K -31,443 Closed
LCM
79
Laurion Capital Management
New York
-$66.4K -26,655 Closed
YIH
80
Y-Intercept (HK)
Hong Kong
-$56.9K -22,855 Closed
SSA
81
Schonfeld Strategic Advisors
New York
-$43.3K -17,400 Closed
Financial Engines Advisors
82
Financial Engines Advisors
California
-$37.6K -15,107 Closed
TSS
83
Two Sigma Securities
New York
-$31.3K -12,587 Closed
Susquehanna International Group
84
Susquehanna International Group
Pennsylvania
-$31.1K -12,471 Closed
SPIA
85
Steward Partners Investment Advisory
New York
-$7.47K -3,000 Closed
Nisa Investment Advisors
86
Nisa Investment Advisors
Missouri
-$1.69K -678 Closed
IGWM
87
ICA Group Wealth Management
Colorado
-$125 -50 Closed